Enabling Accurate Mutation Analysis of FFPE Samples
Targeted sequencing based on NGS offers new perspectives in drug selection for cancer patients. The accuracy of mutation analysis relies on the tumor content of the tissue samples.
Download the recent application note by Dr. Hatakeyama et al. (Shizuoka Cancer Center, Japan) and learn more about:
- How to improve the accuracy of mutation detection in FFPE tissue sections of gastric cancers
- How our FFPE Tissue Dissociation Kit, together with the gentleMACS™ Technology, enables the preparation of single-cell suspensions to separate tumor cells from healthy cells
- How this helps to increase the sequencing sensitivity for FFPE samples